Ian Mcgowan
Chief Medical Officer
Management
Aelix Therapeutics
Spain
Biography
Dr. McGowan previously served as a Principal Investigator of the Microbicide Trials Network (MTN), which focuses on developing topical products for the prevention of HIV infection. He currently leads MTN’s rectal microbicide program, which is based at the University of Pittsburgh. Earlier in his career, he gained in-depth knowledge about drug development, especially antiretroviral therapy, in both academia and commercial organizations. Dr. McGowan also has extensive knowledge of regulatory issues related to drug development and previously served as Chair of the FDA Antiviral Drugs Advisory Committee. During his career, Dr. McGowan has worked as a consultant with several major organizations, such as the WHO and the Centers for Disease Control and Prevention (CDC). Dr. McGowan has authored more than one hundred peer reviewed papers as well as books and book chapters. Dr. McGowan is also journal reviewer at several major life science publications, including the Journal of Virology. He serves on the editorial board of the journal Sexually Transmitted Infections. He has a DPhil in Immunology from Oxford University, an MD from the Liverpool School of Tropical Medicine and is a fellow at the Royal College of Physicians
Research Interest
His area of research interest includes Business Management and technology, drug development, especially antiretroviral therapy and Antiviral Drugs
